June 21, 2018 How are chromosomes arranged in the cell nucleus? Is it possible that they communicate with one another by “touching” each other? To answer this question and to shed more light on the fundamental properties of the communication between different chromosomes, Philipp Maass from Friedrich Luft’s lab at the Max Delbrück Center for […]Continue Reading ...
WEDNESDAY, June 13, 2018 — Use of a negative pressure wound therapy (NPWT) for severe open fracture of the lower limb is not associated with improved self-rated disability at 12 months, compared with standard wound dressing, according to a study published in the June 12 issue of the Journal of the American Medical Association. Matthew […]Continue Reading ...
April 12, 2018 The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Association for Cancer Research (AACR) 2018 Annual Meeting in Chicago. Ciclopirox Prodrug was discovered by researchers at The University of Kansas Cancer Center and KU’s Institute […]Continue Reading ...
March 1, 2018 Fear protects people from danger. A team from the Technical University of Munich (TUM) and Helmholtz Zentrum München has discovered that this applies even to pathological anxiety disorders. Patients who generally suffer from severe anxiety are likely to heed the symptoms of a heart attack earlier and seek medical treatment sooner, thus […]Continue Reading ...
March 1, 2018 Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes. That gene, KRAS, is mutated in approximately 20 percent of all human cancers and has a major presence in […]Continue Reading ...
March 2, 2018 A metal plate might be the cure for a common foot injury seen in athletes and people on their feet all day, according to new research conducted at Houston Methodist. In a paper published online February 21 by The American Journal of Sports Medicine, researchers led by Kevin Varner, M.D., a Houston […]Continue Reading ...
March 2, 2018 New research has found no evidence Omega-3 fish oil supplements help aid or improve the reading ability or memory function of underperforming school-children. These findings are in contradiction to an earlier study run by the same team using the same supplement. In the second high-quality trial of its kind, published in PLOS-ONE, […]Continue Reading ...
Gilead’s Biktarvy Cleared for Use in HIV-1 Infection In February, the FDA approved Gilead’s Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide, or BIC/FTC/TAF), a combination, once-daily, oral treatment for HIV-1 infection in adults. Biktarvy is used for the treatment of two HIV groups: either those who have no antiretroviral treatment history or those who are virologically […]Continue Reading ...
Basel, April 30, 2018 – Novartis announced new positive brolucizumab (RTH258) data in neovascular age-related macular degeneration (nAMD) from a pre-specified secondary analysis of the Phase III HAWK and HARRIER trials. The findings showed that patients assessed as appropriate for a 12-week treatment frequency during the first 12-week cycle after loading could reliably stay on […]Continue Reading ...
March 15, 2018 A study by the Harvard Pilgrim Health Care Institute found that contrary to current hepatitis C treatment guidelines, an eight-week treatment regimen may be just as effective as 12 weeks in black patients. The new study of more than 2,600 patients in Kaiser Permanente’s Northern California region also showed that more people […]Continue Reading ...
Credit: CC0 Public Domain A diet rich in saturated fat and sugar not only leads to obesity, it creates inflammation in the nucleus accumbens, a part of the brain that controls mood and the feeling of reward. And this inflammation can lead to depressive, anxious and compulsive behaviour and disrupt metabolism, according to a new […]Continue Reading ...
Sorrento Therapeutics Subsidiary, Scilex, Receives FDA Approval for Non-Opioid ZTlido (lidocaine topical system) 1.8% for Post-Herpetic Neuralgia Pain SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ:SRNE) (“Sorrento”), and its majority-owned subsidiary, Scilex Pharmaceuticals Inc. (“Scilex”), received approval from the U.S. Food and Drug Administration (FDA) for ZTlido (lidocaine topical system) 1.8%. […]Continue Reading ...
ATLANTA — Hepatitis A vaccination should be given following exposure in all persons ages 12 months and older, the Advisory Committee on Immunization Practices (ACIP) said. In a unanimous 14-0 vote, the ACIP voted that “hepatitis A vaccines should be administered as post-exposure prophylaxis,” for this population, and immune globulin should be administered to adults […]Continue Reading ...
Credit: Yale University Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes. That gene, KRAS, is mutated in approximately 20 percent of all human cancers and has a major presence in […]Continue Reading ...
February 27, 2018 Health authorities will need to focus on more than eating habits if they are going to combat the obesity epidemic. A study led by the University of Waterloo found it’s generally a combination of unhealthy behaviors among youth that could be the greatest predictors of whether or not young people will experience […]Continue Reading ...
- Team explores diabetes drug’s ability to treat RSV infection
- New imaging technique can spot tuberculosis infection in an hour | News Center
- PolyU researchers design new self-fitting scaffold to induce bone regeneration
- CartiHeal and LSU Health successfully enroll first two patients in Agili-C IDE pivotal study
- Less-invasive options are slowing disease progression in glaucoma patients
- Researchers discover new promising target point for cancer and diabetes therapies
- Podcast: KHN’s ‘What the Health?’ See you in court!
- New mobile phone application enables early detection of cerebral ictus
- UK’s leading sight loss charity invites applications from brightest minds in ophthalmic research
- Researchers produce artificial placenta model that closely resembles natural organ
- FDA Alert: Temporary Total Artificial Heart Companion 2 Driver System by SynCardia Systems: Letter to Health Care Providers
- Researchers discover why sepsis from a staph infection causes organ failure
- Revealed: The molecular mechanism underlying hypertrophic cardiomyopathy | News Center
- Research explores relationship between personal history of infectious fever and cancer risk
- Study finds rise in cases of progressive massive fibrosis among U.S. coal miners
- NEDBELS project examines impact of neurodiversity concept on legal systems
- Seeking solutions to treat scleroderma
- Statins may improve conditions of people with rare lung disease
- Study finds why some people with brain markers of Alzheimer’s never develop dementia
- Life Biosciences contributes $100,000 to fund its biomedical innovation course on aging